Clinical Trial Update: CAR-T Cell Therapy Targeting to CD19 for R/R ALL [Phase 1, Phase 2]

View source ↗

Summary

An ongoing phase 1/2 clinical trial is evaluating a CD19-targeted CAR-T cell therapy for relapsed/refractory acute lymphoblastic leukemia, currently recruiting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• CD19-targeted CAR-T cell therapy

Snippet

Sponsor: The First Affiliated Hospital of Soochow University | Conditions: Acute Lymphoblastic Leukemia With Failed Remission | Phase 1, Phase 2 | Status: RECRUITING